Products
Online Inquiry
SNX-2112 (PF-04928473)
Cat. No.:
OB0225WX-2506
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
SNX-2112 (PF-04928473) is a selective ligand that binds to the ATP-binding pocket of both HSP90-alpha and HSP90-beta with a binding affinity (Ka) of 30 nM.
Synonym:
908112-43-6; SNX-2112; 4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide; PF-04928473; 4-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-5,7-dihydroindazol-1-yl]-2-[(4-hydroxycyclohexyl)amino]benzamide; 4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-(((1r,4r)-4-hydroxycyclohexyl)amino)benzamide; 4-[6,6-Dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]-2-[(cis-4-hydroxycyclohexyl)amino]benzamide; Benzamide, 2-((trans-4-hydroxycyclohexyl)amino)-4-(4,5,6,7-tetrahydro-6,6-dimethyl-4-oxo-3-(trifluoromethyl)-1H-indazol-1-yl)-; 4-(6,6-Dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((trans-4-hydroxycyclohexyl)amino)benzamide; 4-(6,6-dimethyl-4-oxo-3-trifluoromethyl-4,5,6,7-tetrahydro-indazol-1-yl)-2-(trans-4-hydroxy-cyclohexylamino)-benzamide; 4-[6,6-dimethyl-4-oxidanylidene-3-(trifluoromethyl)-5,7-dihydroindazol-1-yl]-2-[(4-oxidanylcyclohexyl)amino]benzamide; 4-(6,6-Dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-(trans-4-hydroxycyclohexylamino)benzamide; 4-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1h-indazol-1-yl]-2-[(4-hydroxycyclohexyl)amino]benzamide
CAS No.:
908112-43-6
Compound CID:
24772860
Formula:
C23H27F3N4O3
Formula Weight:
464.48
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
SNX-2112 (PF-04928473) is applied in proteostasis research as a potent Hsp90 inhibitor to study the degradation of oncogenic client proteins and the modulation of the cellular stress response.
Library Information
Target:
HSP (HSP90)
Receptor:
HSP90α; HSP90β
Pathways:
Cytoskeletal signaling
Plate Number:
L6700-04
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
93 mg/mL; 200.22 mM
Ethanol Max Solubility:
1 mg/mL
ALogP:
3.709
HBA_Count:
3
HBD_Count:
3
Rotatable Bond:
5





